Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

Phibro Animal Health (PAHC) Share-based Compensation (2018 - 2026)

Phibro Animal Health has reported Share-based Compensation over the past 6 years, most recently at $180000.0 for Q4 2025.

For Q4 2025, Share-based Compensation changed 0.0% year-over-year to $180000.0; the TTM value through Dec 2025 reached $877000.0, up 30.31%, while the annual FY2025 figure was $717000.0, 50.95% up from the prior year.
Share-based Compensation for Q4 2025 was $180000.0 at Phibro Animal Health, down from $339000.0 in the prior quarter.
Over five years, Share-based Compensation peaked at $339000.0 in Q3 2025 and troughed at $80000.0 in Q4 2023.
A 3-year average of $171100.0 and a median of $179000.0 in 2024 define the central range for Share-based Compensation.
Biggest five-year swings in Share-based Compensation: soared 125.0% in 2024 and later changed 0.0% in 2025.
Year by year, Share-based Compensation stood at $80000.0 in 2023, then soared by 125.0% to $180000.0 in 2024, then changed by 0.0% to $180000.0 in 2025.
Business Quant data shows Share-based Compensation for PAHC at $180000.0 in Q4 2025, $339000.0 in Q3 2025, and $179000.0 in Q2 2025.